InvestorsHub Logo
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 937

Wednesday, 06/03/2009 2:05:48 AM

Wednesday, June 03, 2009 2:05:48 AM

Post# of 1367
Kamada has submitted a BLA to the FDA for its lead clinical candidate, intravenous alpha-1 antitrypsin, for the treatment of AAT.

http://www.globes.co.il/serveen/globes/docview.asp?did=1000454873&fid=942
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.